Adma Biologics (ADMA)

$8.41 +0.53 (6.73%)
Market Cap 1.88B
Revenue (ttm) 510.17M
Net Income (ttm) 146.93M
EPS (ttm) N/A
PE Ratio 11.67
Forward PE 9.73
Profit Margin 28.80%
Debt to Equity Ratio 0.50
Volume 8,219,300
Avg Vol 8,013,602
Day's Range N/A - N/A
Shares Out 238.16M
Stochastic %K 27%
Beta 0.83
Analysts Sell
Price Target $16.67

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the tre...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 478 5552
Fax: 201 478 5553
Address:
465 State Route 17, Ramsey, United States
VoxGeorge
VoxGeorge May. 13 at 11:24 AM
$ADMA
0 · Reply
baston
baston May. 13 at 6:22 AM
$ADMA Remember Steve Elms bought in March. Remember the buy back in March. Would they do that if everything was looking ugly for the future? Don't think so. Wall street saw the negative things about last ER, but there were also positive signals, that in combination with buys/buy back makes me think better times are ahead.
1 · Reply
baston
baston May. 13 at 6:14 AM
$ADMA First buy is inn. Good start. Hoping for Adam and Kwon or others to follow. That in combination with further buyback would do good to the share price.
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 13 at 12:37 AM
$ADMA tomm kwon bomb buys shares
1 · Reply
Ghrr
Ghrr May. 12 at 10:01 PM
$ADMA Jerrold Grossman just bought 12,500 at $8.01. Shows that the execs have faith in the company. Link is to SEC Form 4. https://ir.admabiologics.com/node/13241/html
2 · Reply
Mortimer2020
Mortimer2020 May. 12 at 9:39 PM
$ADMA
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 9:32 PM
$ADMA called it adam loaded today
0 · Reply
StockBraker
StockBraker May. 12 at 7:10 PM
$ADMA stands for All Done Monkeying About.
1 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 6:52 PM
$ADMA live look at Adam picking up some shares
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 6:02 PM
$ADMA maybe the old bidder is interested again
1 · Reply
Latest News on ADMA
$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

May 11, 2026, 6:15 AM EDT - 2 days ago

$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

May 8, 2026, 6:07 AM EDT - 5 days ago

$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

Adma Biologics price target lowered to $20 from $24 at Mizuho

2026-05-07T16:02:55.000Z - 5 days ago

Adma Biologics price target lowered to $20 from $24 at Mizuho

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

May 7, 2026, 9:16 AM EDT - 5 days ago

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

Adma Biologics price target lowered to $18 from $21 at Canaccord

2026-05-07T10:48:12.000Z - 6 days ago

Adma Biologics price target lowered to $18 from $21 at Canaccord

Adma Biologics options imply 12.3% move in share price post-earnings

2026-05-07T02:03:52.000Z - 6 days ago

Adma Biologics options imply 12.3% move in share price post-earnings

Adma Biologics reports Q1 EPS 19c, consensus 20c

2026-05-07T00:37:49.000Z - 6 days ago

Adma Biologics reports Q1 EPS 19c, consensus 20c

Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M

2026-05-07T00:36:02.000Z - 6 days ago

Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M

ADMA Biologics Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 6 days ago

ADMA Biologics Earnings Call Transcript: Q1 2026

ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update

May 6, 2026, 4:05 PM EDT - 6 days ago

ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update

$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

May 6, 2026, 6:41 AM EDT - 7 days ago

$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

Adma Biologics announces FDA approval for Asceniv sBLA

2026-05-04T11:31:54.000Z - 9 days ago

Adma Biologics announces FDA approval for Asceniv sBLA

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

May 4, 2026, 7:00 AM EDT - 9 days ago

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

May 1, 2026, 6:16 AM EDT - 12 days ago

Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 29, 2026, 7:00 AM EDT - 14 days ago

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

Apr 29, 2026, 6:41 AM EDT - 14 days ago

$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

Apr 27, 2026, 6:38 AM EDT - 16 days ago

ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

Apr 22, 2026, 6:05 AM EDT - 21 days ago

$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

Adma Biologics initiated with a Buy at Canaccord

2026-04-21T09:25:41.000Z - 22 days ago

Adma Biologics initiated with a Buy at Canaccord

Adma Biologics initiated with a Buy at Canaccord

2026-04-20T20:45:12.000Z - 22 days ago

Adma Biologics initiated with a Buy at Canaccord

ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

Apr 20, 2026, 6:33 AM EDT - 23 days ago

ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

Apr 17, 2026, 2:33 PM EDT - 25 days ago

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

Stock Notification: ADMA Biologics (NASDAQ:ADMA) Securities Fraud Investigation Over Channel Stuffing Claims is Ongoing – Contact BFA Law if You Lost Money

Apr 17, 2026, 6:46 AM EDT - 26 days ago

Stock Notification: ADMA Biologics (NASDAQ:ADMA) Securities Fraud Investigation Over Channel Stuffing Claims is Ongoing – Contact BFA Law if You Lost Money

$ADMA Legal News: ADMA Biologics Investors may have been Affected by Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law if You Lost Money

Apr 15, 2026, 6:07 AM EDT - 4 weeks ago

$ADMA Legal News: ADMA Biologics Investors may have been Affected by Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law if You Lost Money

Adma Biologics price target lowered to $24 from $30 at Mizuho

2026-04-13T14:43:12.000Z - 4 weeks ago

Adma Biologics price target lowered to $24 from $30 at Mizuho

$ADMA Investigation Reminder: ADMA Biologics Investors are Reminded to Contact BFA Law after Company Investigated for Securities Fraud Over Channel Stuffing Claims

Apr 13, 2026, 6:35 AM EDT - 4 weeks ago

$ADMA Investigation Reminder: ADMA Biologics Investors are Reminded to Contact BFA Law after Company Investigated for Securities Fraud Over Channel Stuffing Claims

ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law

Apr 9, 2026, 6:07 AM EDT - 4 weeks ago

ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law

ADMA Investor Announcement: ADMA Biologics Investigated After Channel Stuffing Claims Cause 29% Stock Drop – Investors with Losses Notified to Contact BFA Law

Apr 8, 2026, 6:16 AM EDT - 5 weeks ago

ADMA Investor Announcement: ADMA Biologics Investigated After Channel Stuffing Claims Cause 29% Stock Drop – Investors with Losses Notified to Contact BFA Law

Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Investors Urged to Contact BFA Law

Apr 6, 2026, 6:18 AM EDT - 5 weeks ago

Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Investors Urged to Contact BFA Law

$ADMA Stock News: ADMA Biologics Investigated for Securities Fraud Following Channel Stuffing Claims – Investors Notified to Contact BFA Law

Apr 3, 2026, 6:46 AM EDT - 5 weeks ago

$ADMA Stock News: ADMA Biologics Investigated for Securities Fraud Following Channel Stuffing Claims – Investors Notified to Contact BFA Law

ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop

Mar 31, 2026, 6:07 AM EDT - 6 weeks ago

ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop

$ADMA Investor News: ADMA Biologics Faces Securities Fraud Investigation after Culper Research Revelation Leads to 29% Stock Drop – BFA Law Notifies Investors to Act

Mar 30, 2026, 6:07 AM EDT - 6 weeks ago

$ADMA Investor News: ADMA Biologics Faces Securities Fraud Investigation after Culper Research Revelation Leads to 29% Stock Drop – BFA Law Notifies Investors to Act

Adma Biologics call volume above normal and directionally bullish

2026-03-27T15:45:13.000Z - 6 weeks ago

Adma Biologics call volume above normal and directionally bullish

Adma Biologics responds to short seller report by Culper Research

2026-03-27T11:42:03.000Z - 6 weeks ago

Adma Biologics responds to short seller report by Culper Research

ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

Mar 27, 2026, 7:00 AM EDT - 6 weeks ago

ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

$ADMA Shareholders: ADMA Biologics Hit with Securities Fraud Investigation After Stock Slides 29% Amid Channel Stuffing Claims – Investors with Losses Alerted to Contact BFA Law

Mar 27, 2026, 6:18 AM EDT - 6 weeks ago

$ADMA Shareholders: ADMA Biologics Hit with Securities Fraud Investigation After Stock Slides 29% Amid Channel Stuffing Claims – Investors with Losses Alerted to Contact BFA Law

ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA Law

Mar 26, 2026, 2:34 PM EDT - 6 weeks ago

ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA Law

Adma Biologics falls -15.9%

2026-03-26T16:06:09.000Z - 6 weeks ago

Adma Biologics falls -15.9%

Adma Biologics falls -19.9%

2026-03-26T14:07:02.000Z - 6 weeks ago

Adma Biologics falls -19.9%

Cantor downgrades Adma Biologics on lack of clarity post short report

2026-03-26T08:50:09.000Z - 6 weeks ago

Cantor downgrades Adma Biologics on lack of clarity post short report

Adma Biologics says Culper report contains ‘inaccurate statements’

2026-03-25T23:25:28.000Z - 6 weeks ago

Adma Biologics says Culper report contains ‘inaccurate statements’

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

2026-03-25T23:25:22.000Z - 6 weeks ago

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

Adma Biologics falls -12.6%

2026-03-25T16:06:37.000Z - 6 weeks ago

Adma Biologics falls -12.6%

Adma Biologics addresses misleading report by Culper Research

2026-03-25T10:38:01.000Z - 7 weeks ago

Adma Biologics addresses misleading report by Culper Research

ADMA Biologics Addresses Misleading Short-Seller Report

Mar 25, 2026, 6:30 AM EDT - 7 weeks ago

ADMA Biologics Addresses Misleading Short-Seller Report

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

Mar 2, 2026, 7:00 AM EST - 2 months ago

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

ADMA Biologics Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 2 months ago

ADMA Biologics Earnings Call Transcript: Q4 2025

ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 25, 2026, 4:05 PM EST - 2 months ago

ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Feb 18, 2026, 7:00 AM EST - 3 months ago

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

ADMA Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:45 PM EST - 4 months ago

ADMA Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

Jan 12, 2026, 8:00 AM EST - 4 months ago

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

Jan 5, 2026, 7:00 AM EST - 4 months ago

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

ADMA Biologics Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 6 months ago

ADMA Biologics Earnings Call Transcript: Q3 2025

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

Nov 5, 2025, 4:05 PM EST - 6 months ago

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

VoxGeorge
VoxGeorge May. 13 at 11:24 AM
$ADMA
0 · Reply
baston
baston May. 13 at 6:22 AM
$ADMA Remember Steve Elms bought in March. Remember the buy back in March. Would they do that if everything was looking ugly for the future? Don't think so. Wall street saw the negative things about last ER, but there were also positive signals, that in combination with buys/buy back makes me think better times are ahead.
1 · Reply
baston
baston May. 13 at 6:14 AM
$ADMA First buy is inn. Good start. Hoping for Adam and Kwon or others to follow. That in combination with further buyback would do good to the share price.
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 13 at 12:37 AM
$ADMA tomm kwon bomb buys shares
1 · Reply
Ghrr
Ghrr May. 12 at 10:01 PM
$ADMA Jerrold Grossman just bought 12,500 at $8.01. Shows that the execs have faith in the company. Link is to SEC Form 4. https://ir.admabiologics.com/node/13241/html
2 · Reply
Mortimer2020
Mortimer2020 May. 12 at 9:39 PM
$ADMA
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 9:32 PM
$ADMA called it adam loaded today
0 · Reply
StockBraker
StockBraker May. 12 at 7:10 PM
$ADMA stands for All Done Monkeying About.
1 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 6:52 PM
$ADMA live look at Adam picking up some shares
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 6:02 PM
$ADMA maybe the old bidder is interested again
1 · Reply
DoctorLeoMarvin
DoctorLeoMarvin May. 12 at 5:48 PM
$ADMA I told you, girl!
1 · Reply
Bigg554
Bigg554 May. 12 at 5:45 PM
$ADMA I’m holding long, but what’s with movement today? I thought it dipped so low a buyout may be happening any thoughts?
0 · Reply
nyzgujuboi89
nyzgujuboi89 May. 12 at 5:09 PM
$ADMA so when is $10 👀
0 · Reply
GoldmanSlaps
GoldmanSlaps May. 12 at 4:46 PM
$ADMA
1 · Reply
DoctorLeoMarvin
DoctorLeoMarvin May. 12 at 3:29 PM
$ADMA let’s hit the bullseye!
1 · Reply
BullMaven
BullMaven May. 12 at 3:14 PM
$ADMA no brainer. extremely undervaled. loading as much as I can anything below 10
0 · Reply
VoxGeorge
VoxGeorge May. 12 at 1:34 PM
$ADMA
0 · Reply
mhkmjk
mhkmjk May. 12 at 6:10 AM
$ADMA Assuming the given 2026 revenue guidance ($530-560M) realized, a realistic split between the key products could be Asceniv $450M (vs $363M in 2025) and Bivigam (+other) $80M (vs $147M in 2025). Asceniv growth needs to continue strong to hit the given guidance.
1 · Reply
uhhhhhhhhhhh
uhhhhhhhhhhh May. 12 at 4:45 AM
$ADMA mega load zone imo. Maybe it'll keep getting shit on until a rev recovery but financials are too juicy at this level even with the revenue crunch. Margins are great and fcf yield is good here. Competitive headwinds likely exempt asceniv... no real competing "last resort" high titer products. Just my opinion.
1 · Reply
DayTrader2025
DayTrader2025 May. 12 at 12:20 AM
$ADMA maybe?
1 · Reply
BioBum
BioBum May. 11 at 9:42 PM
$ADMA holy shit. Sorry long, longs. Brutal. Road her from 2.50 to 10. Kicked myself when it got to $20
0 · Reply
USMAgrad
USMAgrad May. 11 at 9:02 PM
$ADMA I will hang out here for another quarter just to see what pediatric approval translates to. I have 5K shares at $9.50 avg Agnostic about possibilities for growth but this being under $10 feels criminal at this point
0 · Reply